22 completed, 13 unknown, 4 not yet recruiting, 2 recruiting. 26 Not applicable, 7 Phase 3, 6 Phase 2, 3 Phase 1, 1 Phase 4.
Follow Test group: new trials by email Literature Review of Test group trials Research Report on Test group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation DN022150+AG( Stage I ）, DN022150+AG（Stage II）, placebo+AG（Stage II） - Pancreatic Cancer, Pancreatic Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 465 | 2027-06-06 | 2026-06-18 |
| Immediate Restoration of a New Implant With High Primary Stability Control Group, Test group - Implant restoration with a temporary crown - Dental Implants, Immediate Dental Implant Loading | Not applicable | Not yet recruiting | Universidade do Porto | 50 | 2026-07-01 | 2026-05-05 |
| Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus Test group, Exploratory test group, Control group 1 - Hypertension, Diabete Type 2 | Phase 3 | Recruiting | Hanlim Pharm. Co., Ltd. | 228 | 2025-12-18 | 2026-04-27 |
| Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination Placebo Group, Test Group - Prevention of Influenza | Phase 3 | Not yet recruiting | Changchun BCHT Biotechnology Co. | 6680 | 2025-08-01 | 2025-08-21 |
| Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants Group A, Reference Group - Bioequivalence | Phase 1 | Not yet recruiting | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 110 | 2025-02-01 | 2025-02-17 |
| Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer Test group, Reference group - Insufficient Breast Milk Syndrome, Premature Birth | Enrolling by invitation | Centro Hospitalar de Lisboa Central | 81 | 2025-01-08 | 2025-03-18 | |
| The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy Test group, Control group - Upper Gastrointestinal Endoscopy | Not applicable | Completed | Carol Davila University of Medicine and Pharmacy | 42 | 2024-08-01 | 2024-11-12 |
| To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer Probiotic, Placebo - Breast Cancer | Not applicable | Recruiting | GenMont Biotech Incorporation | 100 | 2024-04-08 | 2026-03-06 |
| Pregabalin as an add-on Therapy to Carbamazepine in Trigeminal Neuralgia Patients Pregabalin and Carbamazepine, Carbamazepine - Trigeminal Neuralgia | Not applicable | Unknown | Postgraduate Institute of Dental Sciences Rohtak | 50 | 2024-04-01 | 2024-06-10 |
| SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19) SHEN211 Tablets, Placebo for SHEN211 Tablets - COVID-19 | Phase 2 | Unknown | JKT Biopharma Co., Ltd. | 30 | 2024-04-01 | 2024-03-04 |
| Clinical Study of GKT in Diabetes Related Dementia Ginkgo Ketone Ester Tablets, placebo - Dementia | Phase 4 | Unknown | Shanghai 10th People's Hospital | 370 | 2023-12-01 | 2023-11-13 |
| Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients AJU-S56 5%, Placebo Group(Vehicle) - Dry Eye Syndromes | Phase 3 | Unknown | AJU Pharm Co., Ltd. | 396 | 2023-11-10 | 2024-04-08 |
| Probiotics in Special Needs Patients at High Risk for Tooth Decay: a Randomized Controlled Trial. Test Group, Positive Control, Negative Control - Tooth Decay, Intellectual Disability | Not applicable | Unknown | G. d'Annunzio University | 70 | 2023-10-01 | 2023-10-04 |
| Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery Control Group, Test Group - Voiding Dysfunction | Not applicable | Completed | Wake Forest University Health Sciences | 100 | 2023-07-11 | 2024-04-29 |
| MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance Manzi Guben granules - COVID-19 | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 360 | 2023-06-01 | 2023-02-10 |
| To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota Modulation Probiotic group, Placebo group - Diabetic Kidney Disease | Not applicable | Completed | GenMont Biotech Incorporation | 50 | 2023-04-24 | 2025-12-08 |
| Effects of the Adjunctive Use of Hyaluronic Acid-based Gel in the Surgical Periodontal Treatment of Periodontitis open flap debridement and Hyaluronic Acid-Based Gel application, open flap debridement - Periodontitis (Stage 3) | Phase 1 / Phase 2 | Completed | Ordu University | 18 | 2023-04-04 | 2025-02-24 |
| To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation Placebo, Probiotics - Non-Alcoholic Fatty Liver Disease | Not applicable | Completed | GenMont Biotech Incorporation | 70 | 2022-07-14 | 2024-07-05 |
| Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases Control Group, Test Group - Pelvic Inflammatory Disease | Phase 2 | Completed | University of Karachi | 198 | 2021-09-21 | 2023-04-04 |
| Narrow Implants Vs Standard Implants With Simultaneous GBR Test group, Control group - Narrow Implant, Dental Implant | Not applicable | Completed | Universitat Internacional de Catalunya | 30 | 2021-07-12 | 2026-03-11 |
Showing 20 of 44. Sign in to see all of them.
COVID-19 (2) · Bone Diseases, Metabolic (1) · Brain Injuries, Traumatic (1) · Breast Neoplasms (1) · Chronic Periodontitis (1) · Cough (1) · Dementia (1) · Dental Caries (1) · Dentin Sensitivity (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Dry Eye Syndromes (1) · Dyspnea (1) · Health Behavior (1) · Hypertension (1)
GenMont Biotech Incorporation (3) · Mashhad University of Medical Sciences (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Sun Yat-sen University (2) · University of Belgrade (2) · AJU Pharm Co., Ltd. (1) · Alvogen Korea (1) · AstraZeneca (1) · Cairo University (1) · Carol Davila University of Medicine and Pharmacy (1) · Centro Hospitalar de Lisboa Central (1) · Changchun BCHT Biotechnology Co. (1) · Dr. Tikfu Gee (1) · FBM Industria Brasileira Ltda (1) · G. d'Annunzio University (1)
China (4) · Iran (3) · Italy (3) · South Korea (3) · Taiwan (3) · India (2) · Portugal (2) · Serbia (2) · Spain (2) · Turkey (Türkiye) (2) · Australia (1) · France (1) · Malaysia (1) · Pakistan (1) · Romania (1)
Abdulrahman Alshehri, MS (1) · Aleksa Markovic, Professor (1) · Alessandro Silva, Director (1) · Amir Moeintaghavi, DDS.,Ms. (1) · Chi-Yang Chang, PhD (1) · Daniel Virella, MD, MSc (1) · David Lovejoy, MD (1) · David MG Halpin, MBBS, MRCP, FRCP (1) · Fei Xiong, M.D. (1) · Hadar Zigdon, Dr. (1) · Hongying Yang, MD (1) · Hongzhou Lu, ph.D (1) · Jianghua Chen, M.D. & Ph.D (1)
PMID 11444448, PMID 12452227, PMID 12841551, PMID 16036192, PMID 16703434, PMID 17324772, PMID 17653742, PMID 20370417, PMID 20605604, PMID 22369555, PMID 22763212, PMID 23248560, PMID 23594859, PMID 24405824, PMID 25926349, PMID 26289708, PMID 26531676, PMID 26694786, PMID 27007272, PMID 27109174, PMID 28652142, PMID 29789771, PMID 30513944, PMID 32792449, PMID 34937085, PMID 35822682, PMID 36986263, PMID 37382408, PMID 38584600, PMID 38757854, PMID 42827082, PMID 8295089